サンプル依頼リスト カート
  • English
  • Korean
デフォルト表紙
市場調査レポート
商品コード
1386417

心的外傷後ストレス障害（PTSD）市場レポート：2030年までの動向、予測、競合分析

Post-Traumatic Stress Disorder (PTSD) Market Report: Trends, Forecast and Competitive Analysis to 2030

出版日
発行
Lucintel
ページ情報
英文 150 Pages
納期
3営業日
カスタマイズ可能
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.99円

ご注意:　DRM (デジタル著作権管理システム) 付PDFになります。
制限内容は、上記ライセンスの[詳細]アイコンをクリックしてご確認ください。

心的外傷後ストレス障害（PTSD）市場レポート：2030年までの動向、予測、競合分析
出版日: 2023年10月03日
発行: Lucintel
ページ情報: 英文 150 Pages
納期: 3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

心的外傷後ストレス障害（PTSD）の動向と予測

世界の心的外傷後ストレス障害（PTSD）市場は、2024年から2030年までのCAGRが4.6％で、2030年までに推定14億米ドルに達すると予測されます。この市場の主な促進要因は、心的外傷後ストレス障害の有病率の増加、メンタルヘルス問題に対する意識の高まり、心的外傷後ストレス障害の治療に関する研究開発活動の急増に伴うメンタルヘルスサービスの需要拡大です。世界の心的外傷後ストレス障害（PTSD）市場の将来性は、病院や診療所市場における機会によって有望視されています。

心的外傷後ストレス障害（PTSD）市場の洞察

Lucintelの予測では、この年齢層の患者数の多さ、成人層における精神疾患患者の増加、トラウマ体験の増加により、予測期間中、成人層が引き続き大きな市場規模を占めると思われます。

この市場において、病院は、急性危機を管理する能力とともに、心的外傷後ストレス障害症例の診断と治療のためのプライマリヘルスケアの場において重要であるため、より大きなセグメントであり続けると思われます。

北米は、心的外傷後ストレス障害の有病率が増加し、メンタルヘルスケアサービスの需要が高まっていることから、引き続き最大の地域となるでしょう。

本レポートでは、以下の11の主要な質問に回答している：

  • Q.1.市場セグメントのうち、最も有望かつ高成長な機会は何か？
  • Q.2.どのセグメントがより速いペースで成長するのか、またその理由は？
  • Q.3.今後成長が加速すると思われる地域とその理由は？
  • Q.4.市場力学に影響を与える主な要因は何か？市場における主な課題とビジネスリスクは？
  • Q.5.この市場におけるビジネスリスクと競合の脅威は？
  • Q.6.この市場における新たな動向とその理由は？
  • Q.7.市場における顧客の需要の変化にはどのようなものがありますか？
  • Q.8.この市場における新たな開発と、その開発をリードしている企業は？
  • Q.9.この市場における主要企業は？主要企業は事業成長のためにどのような戦略的取り組みを進めているのか？
  • Q.10.この市場における競合製品にはどのようなものがあり、材料や製品の代替による市場シェア低下の脅威はどの程度ありますか？
  • Q.11.過去5年間にどのようなM&Aが行われ、業界にどのような影響を与えましたか？

目次

第1章 エグゼクティブサマリー

第2章 世界の心的外傷後ストレス障害（PTSD）市場：市場力学

  • イントロダクション、背景、分類
  • サプライチェーン
  • 業界の促進要因と課題

第3章 2018年から2030年までの市場動向と予測分析

  • マクロ経済動向（2018～2023年）と予測（2024～2030年）
  • 世界の心的外傷後ストレス障害（PTSD）市場動向（2018～2023年）と予測（2024～2030年）
  • 製品タイプ別の世界の心的外傷後ストレス障害（PTSD）市場
    • 抗うつ薬
    • 認知療法
    • 抗不安薬
    • 曝露療法
    • 眼球運動の減感作と再処理（EMDR）
    • PSTDの治療法
  • 年齢層別の世界の心的外傷後ストレス障害（PTSD）市場
    • 子供
    • 大人
  • 最終用途別の世界の心的外傷後ストレス障害（PTSD）市場
    • 病院
    • クリニック

第4章 2018年から2030年までの地域別の市場動向と予測分析

  • 地域別の世界の心的外傷後ストレス障害（PTSD）市場
  • 北米の心的外傷後ストレス障害（PTSD）市場
  • 欧州の心的外傷後ストレス障害（PTSD）市場
  • アジア太平洋心的外傷後ストレス障害（PTSD）市場
  • その他地域心的外傷後ストレス障害（PTSD）市場

第5章 競合の分析

  • 製品ポートフォリオ分析
  • 運用上の統合
  • ポーターのファイブフォース分析

第6章 成長機会と戦略分析

  • 成長機会分析
    • 製品タイプ別の世界の心的外傷後ストレス障害（PTSD）市場の成長機会
    • 年齢層別の世界の心的外傷後ストレス障害（PTSD）市場の成長機会
    • 最終用途別の世界の心的外傷後ストレス障害（PTSD）市場の成長機会
    • 地域別の世界の心的外傷後ストレス障害（PTSD）市場の成長機会
  • 世界の心的外傷後ストレス障害（PTSD）市場の新たな動向
  • 戦略的分析
    • 新製品の開発
    • 世界の心的外傷後ストレス障害（PTSD）市場の能力拡大
    • 世界の心的外傷後ストレス障害（PTSD）市場における合併、買収、合弁事業
    • 認証とライセンシング

第7章 有力企業の企業プロファイル

  • GlaxoSmithKline
  • Pfizer
  • Eli Lilly & Company
  • Azevan Pharmaceuticals
  • Otsuka Pharmaceutical
  • AstraZeneca
  • Neurocrine Biosciences
  • Nuvo Pharmaceuticals
  • Marinus Pharmaceuticals
  • Tonix Pharmaceuticals
目次

Post-Traumatic Stress Disorder (PTSD) Trends and Forecast

The future of the global post-traumatic stress disorder (PTSD) market looks promising with opportunities in the hospital and clinic markets. The global post-traumatic stress disorder (PTSD) market is expected to reach an estimated $1.4 billion by 2030 with a CAGR of 4.6% from 2024 to 2030. The major drivers for this market are increasing prevalence of post-traumatic stress disorders, rising awareness towards mental health issues, and growing demand of mental health services along with surhing R&D activities for treatment of post-traumatic stress disorders.

A more than 150-page report is developed to help in your business decisions.

Post-Traumatic Stress Disorder (PTSD) by Segment

The study includes a forecast for the global post-traumatic stress disorder (PTSD) by product type, age group, end use, and region.

Post-Traumatic Stress Disorder (PTSD) Market by Product Type [Shipment Analysis by Value from 2018 to 2030]:

  • Antidepressants
  • Cognitive Therapy
  • Anti-Anxiety Drugs
  • Exposure Therapy
  • Eye Movement Desensitization & Reprocessing (EMDR)
  • PSTD Therapeutics

Post-Traumatic Stress Disorder (PTSD) Market by Age Group [Shipment Analysis by Value from 2018 to 2030]:

  • Children
  • Adult

Post-Traumatic Stress Disorder (PTSD) Market by End Use [Shipment Analysis by Value from 2018 to 2030]:

  • Hospitals
  • Clinics

Post-Traumatic Stress Disorder (PTSD) Market by Region [Shipment Analysis by Value from 2018 to 2030]:

  • North America
  • Europe
  • Asia Pacific
  • The Rest of the World

List of Post-Traumatic Stress Disorder (PTSD) Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies post-traumatic stress disorder (PTSD) companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the post-traumatic stress disorder (PTSD) companies profiled in this report include-

  • Glaxosmithkline
  • Pfizer
  • Eli Lilly & Company
  • Azevan Pharmaceuticals
  • Otsuka Pharmaceutical
  • Astrazeneca
  • Neurocrine Biosciences
  • Nuvo Pharmaceuticals
  • Marinus Pharmaceuticals
  • Tonix Pharmaceuticals

Post-Traumatic Stress Disorder (PTSD) Market Insights

Lucintel forecasts that adult will remain the larger semgent over the forecast period due to large number of patients in this age group, growing mental health disorder cases in the adult group, and rising traumatic experiences.

Within this market, hospitals will remain the larger segment due to their importance in primary healthcare settings for the diagnosis and treatment of post-traumatic stress disorder cases along with their capabilities to manage acute crisis.

North America will remain the largest region due to increasing prevalence of post-traumatic stress disorder and growing demand of mental healthcare services in the region.

Features of the Global Post-Traumatic Stress Disorder (PTSD) Market

Market Size Estimates: Post-traumatic stress disorder (PTSD) market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Post-traumatic stress disorder (PTSD) market size by product type, age group, end use, and region in terms of value ($B).

Regional Analysis: Post-traumatic stress disorder (PTSD) market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different product types, age groups, end uses, and regions for the post-traumatic stress disorder (PTSD) market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the post-traumatic stress disorder (PTSD) market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q.1 What is the post-traumatic stress disorder (PTSD) market size?

Answer: The global post-traumatic stress disorder (PTSD) market is expected to reach an estimated $1.4 billion by 2030.

Q.2 What is the growth forecast for post-traumatic stress disorder (PTSD) market?

Answer: The global post-traumatic stress disorder (PTSD) market is expected to grow with a CAGR of 4.6% from 2024 to 2030.

Q.3 What are the major drivers influencing the growth of the post-traumatic stress disorder (PTSD) market?

Answer: The major drivers for this market are increasing prevalence of post-traumatic stress disorders, rising awareness towards mental health issues, and growing demand of mental health services along with surhing R&D activities for treatment of post-traumatic stress disorders.

Q4. What are the major segments for post-traumatic stress disorder (PTSD) market?

Answer: The future of the post-traumatic stress disorder (PTSD) market looks promising with opportunities in the hospital and clinic markets.

Q5. Who are the key post-traumatic stress disorder (PTSD) market companies?

Answer: Some of the key post-traumatic stress disorder (PTSD) companies are as follows:

  • Glaxosmithkline
  • Pfizer
  • Eli Lilly & Company
  • Azevan Pharmaceuticals
  • Otsuka Pharmaceutical
  • Astrazeneca
  • Neurocrine Biosciences
  • Nuvo Pharmaceuticals
  • Marinus Pharmaceuticals
  • Tonix Pharmaceuticals

Q6. Which post-traumatic stress disorder (PTSD) market segment will be the largest in future?

Answer: Lucintel forecasts that adult will remain the larger semgent over the forecast period due to large number of patients in this age group, growing mental health disorder cases in the adult group, and rising traumatic experiences.

Q7. In post-traumatic stress disorder (PTSD) market, which region is expected to be the largest in next 5 years?

Answer: North America will remain the largest region due to increasing prevalence of post-traumatic stress disorder and growing demand of mental healthcare services in the region.

Q.8 Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

  • Q.1. What are some of the most promising, high-growth opportunities for the post-traumatic stress disorder (PTSD) market by product type (antidepressants, cognitive therapy, anti-anxiety drugs, exposure therapy, eye movement desensitization & reprocessing (EMDR), and PSTD therapeutics), age group (children and adult), end use (hospitals and clinics), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
  • Q.2. Which segments will grow at a faster pace and why?
  • Q.3. Which region will grow at a faster pace and why?
  • Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
  • Q.5. What are the business risks and competitive threats in this market?
  • Q.6. What are the emerging trends in this market and the reasons behind them?
  • Q.7. What are some of the changing demands of customers in the market?
  • Q.8. What are the new developments in the market? Which companies are leading these developments?
  • Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
  • Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
  • Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Post-Traumatic Stress Disorder (PTSD) Market : Market Dynamics

  • 2.1: Introduction, Background, and Classifications
  • 2.2: Supply Chain
  • 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

  • 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
  • 3.2. Global Post-Traumatic Stress Disorder (PTSD) Market Trends (2018-2023) and Forecast (2024-2030)
  • 3.3: Global Post-Traumatic Stress Disorder (PTSD) Market by Product Type
    • 3.3.1: Antidepressants
    • 3.3.2: Cognitive Therapy
    • 3.3.3: Anti-Anxiety Drugs
    • 3.3.4: Exposure Therapy
    • 3.3.5: Eye Movement Desensitization & Reprocessing (EMDR)
    • 3.3.6: PSTD therapeutics
  • 3.4: Global Post-Traumatic Stress Disorder (PTSD) Market by Age Group
    • 3.4.1: Children
    • 3.4.2: Adult
  • 3.5: Global Post-Traumatic Stress Disorder (PTSD) Market by End Use
    • 3.5.1: Hospitals
    • 3.5.2: Clinics

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

  • 4.1: Global Post-Traumatic Stress Disorder (PTSD) Market by Region
  • 4.2: North American Post-Traumatic Stress Disorder (PTSD) Market
    • 4.2.1: North American Post-Traumatic Stress Disorder (PTSD) Market by Age Group: Children and Adult
    • 4.2.2: North American Post-Traumatic Stress Disorder (PTSD) Market by End Use: Hospitals and Clinics
  • 4.3: European Post-Traumatic Stress Disorder (PTSD) Market
    • 4.3.1: European Post-Traumatic Stress Disorder (PTSD) Market by Age Group: Children and Adult
    • 4.3.2: European Post-Traumatic Stress Disorder (PTSD) Market by End Use: Hospitals and Clinics
  • 4.4: APAC Post-Traumatic Stress Disorder (PTSD) Market
    • 4.4.1: APAC Post-Traumatic Stress Disorder (PTSD) Market by Age Group: Children and Adult
    • 4.4.2: APAC Post-Traumatic Stress Disorder (PTSD) Market by End Use: Hospitals and Clinics
  • 4.5: ROW Post-Traumatic Stress Disorder (PTSD) Market
    • 4.5.1: ROW Post-Traumatic Stress Disorder (PTSD) Market by Age Group: Children and Adult
    • 4.5.2: ROW Post-Traumatic Stress Disorder (PTSD) Market by End Use: Hospitals and Clinics

5. Competitor Analysis

  • 5.1: Product Portfolio Analysis
  • 5.2: Operational Integration
  • 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

  • 6.1: Growth Opportunity Analysis
    • 6.1.1: Growth Opportunities for the Global Post-Traumatic Stress Disorder (PTSD) Market by Product Type
    • 6.1.2: Growth Opportunities for the Global Post-Traumatic Stress Disorder (PTSD) Market by Age Group
    • 6.1.3: Growth Opportunities for the Global Post-Traumatic Stress Disorder (PTSD) Market by End Use
    • 6.1.4: Growth Opportunities for the Global Post-Traumatic Stress Disorder (PTSD) Market by Region
  • 6.2: Emerging Trends in the Global Post-Traumatic Stress Disorder (PTSD) Market
  • 6.3: Strategic Analysis
    • 6.3.1: New Product Development
    • 6.3.2: Capacity Expansion of the Global Post-Traumatic Stress Disorder (PTSD) Market
    • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Post-Traumatic Stress Disorder (PTSD) Market
    • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

  • 7.1: GlaxoSmithKline
  • 7.2: Pfizer
  • 7.3: Eli Lilly & Company
  • 7.4: Azevan Pharmaceuticals
  • 7.5: Otsuka Pharmaceutical
  • 7.6: AstraZeneca
  • 7.7: Neurocrine Biosciences
  • 7.8: Nuvo Pharmaceuticals
  • 7.9: Marinus Pharmaceuticals
  • 7.10: Tonix Pharmaceuticals